Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
Aclarion presented two abstracts at the ASPN Annual Meeting highlighting the clinical utility of Nociscan in real-world practice and surgical decision support. A prospective study of 20 patients demonstrated successful integration of MR Spectroscopy into clinical workflows, while a separate case study reported 95% pain relief following Nociscan-guided basivertebral nerve ablation.
Key figures
- Patients in study
- 20
- Pain relief percent
- 95
- Market size patients
- 266000000
- Historical surgical success rate
- 97
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.